To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Wandsworth Prison: Health Services
Wednesday 4th December 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made with Cabinet colleagues of the adequacy of healthcare provision in HMP Wandsworth.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

Healthcare services at HMP Wandsworth underwent inspection, jointly undertaken by His Majesty’s Inspectorate of Prisons and the Care Quality Commission, in May 2024. The joint inspectorate noted that improvements had been made across the provision of healthcare since the last inspection. The full report is available at the following link:

https://hmiprisons.justiceinspectorates.gov.uk/hmipris_reports/hmp-wandsworth-3/

NHS England continues to monitor service provision and the quality of the healthcare service, meeting with the healthcare provider on a quarterly basis to discuss quality and assurance matters. Quality and assurance visits to the service are also taking place, attended by the Lead Commissioner and Clinical Quality Lead.


Written Question
Health Services: Prisons
Wednesday 4th December 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the quality of healthcare provision across the prison estate.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

NHS England’s Health and Justice Oversight Delivery Group is responsible for governance and oversight of delivery and continuous improvement in health and justice commissioned services.

NHS England, via the regional health and justice teams, has regular meetings with prison healthcare providers to ensure the quality of the services that are provided.  These are also supplemented with local partnership boards, where governors, commissioners, and providers meet to discuss any issues, risks, and areas of concern.

NHS England also works closely with the Prisons and Probation Ombudsman to identify themes, trends, and learning from recommendations made as part of the investigations into deaths in custody, and also takes learning and insights around preventable events from preventing future deaths reports and commissioner-led complaints.

NHS England is undertaking a review of health and justice service specifications to ensure they remain fit for purpose in relation to patient needs, developments in health and justice, and the wider National Health Service. This review includes engagement with lived experience, commissioners, providers, clinical leads, partner organisations, and stakeholders, along with NHS England directorates. This review of service specifications may also provide opportunities for the improvement of the provision of services. It is expected that publication of the refreshed specifications will start in 2025, and will be fully complete by the end of March 2026.


Written Question
Breast Cancer: Diagnosis
Friday 29th November 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of including breast density in medical data collection, in the context of diagnosing breast cancer.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

The UK National Screening Committee is currently reviewing the evidence surrounding breast density in screening.

Improving early diagnosis of cancer, including breast cancer, is a priority for NHS England. To support early detection and diagnosis, the National Health Service carries out approximately 2.1 million breast cancer screens each year in hospitals and mobile screening vans, usually in convenient community locations.


Written Question
Breast Cancer: Diagnosis
Friday 29th November 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the rate of breast cancer diagnoses for women with asymptomatic breast density.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

The UK National Screening Committee is currently reviewing the evidence surrounding breast density in screening.

Improving early diagnosis of cancer, including breast cancer, is a priority for NHS England. To support early detection and diagnosis, the National Health Service carries out approximately 2.1 million breast cancer screens each year in hospitals and mobile screening vans, usually in convenient community locations.


Written Question
Breast Cancer: Screening
Wednesday 6th November 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the number of breast cancer diagnoses at mammogram or other early stages.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

Lord Darzi’s report has set out the scale of the challenges we face in fixing the National Health Service and the need to improve cancer waiting time performance and cancer survival, including for breast cancer. In particular, he has highlighted the need to improve the number of patients starting their treatment within 62 days of referral and to increase the number of patients diagnosed at an earlier stage.

The Government is committed to meeting all three NHS cancer waiting time standards across England within the next five years. Meeting these will ensure no patient waits longer than they should for diagnosis or treatment.

The NHS Breast Screening Programme offers all women in England from 50 years old up to their 71st birthday the opportunity to be screened every three years for breast cancer, to help detect abnormalities and intervene early to reduce the number of lives lost to invasive breast cancer.

NHS England has also developed a national plan in collaboration with key stakeholders such as cancer alliances to improve uptake within the breast screening programme. The plan sets out the priorities, interventions and monitoring of impact and outcomes to be achieved to improve uptake through: Expanding access, data and analytics, reducing inequalities, contracting, communication and IT developments.


Written Question
Breast Cancer: Screening
Wednesday 6th November 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increasing the (a) acceptable and (b) achievable levels of S07b incident screenings for mammograms.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

As part of the NHS Breast Screening Programme, S07b is the ‘screening standard’ whereby ‘incident screens’, that is any subsequent breast screen after first screen, are referred for further assessment.

NHS England has advised that there is expected to be an initial light touch review of the breast screening standards by the end of March 2025, with a full review of all standards in screening year 2025/6. During the full review in 2025/26, the programme performance in ‘percentage referrals to assessment’ will be reviewed to determine whether the acceptable and achievable limits should be changed.

However, increasing the thresholds for this standard, will mean that the number of women referred for follow up tests, namely biopsy, mammograms, and ultrasound, will increase, many of whom will have no cancer. Screening programmes must continue to maximise benefit while minimising harm.


Written Question
Members: Correspondence
Wednesday 16th October 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when he plans to respond to the correspondence of 7 August 2024 from the hon. Member for Tooting on children's cancer services in the South East.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

We replied to the hon. Member’s letter on 16 September 2024. We apologise for the delay in replying, as this was due to Conference.


Written Question
Methylphenidate
Monday 14th October 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the supply of methylphenidate hydrochloride in pharmacies.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department has been working hard with industry and NHS England to help resolve supply issues with some attention deficit hyperactivity disorder (ADHD) medicines, which are affecting the United Kingdom and other countries around the world. As a result of intensive work, some issues have been resolved. All strengths of lisdexamfetamine, atomoxetine capsules, and guanfacine prolonged-release tablets are now available.

We are continuing to work to resolve medicine supply issues, where they remain, for some strengths of methylphenidate. We are engaging with all suppliers of methylphenidate prolonged-release tablets to assess the challenges faced, and their actions to address them. We are also directing suppliers to secure additional stocks, expedite deliveries where possible, and review plans to further build capacity to support continued growth in demand for the short and long-term. It is anticipated the methylphenidate supply issues will be resolved by October 2024.

In parallel, the Department has worked with specialist clinicians, including those within the National Health Service, to develop management advice for the NHS clinicians to consider prescribing available alternative brands of methylphenidate prolonged release tablets. We would expect ADHD service providers and specialists to follow our guidance to offer rapid response to primary care teams seeking urgent advice or opinion for the management of patients, including those known to be at a higher risk of adverse impact because of these shortages.

To aid ADHD service providers and prescribers further, we have widely disseminated our communications and continually update a list of currently available and unavailable ADHD products on the Specialist Pharmacy Service website, helping ensure that those involved in the prescribing and dispensing of ADHD medications can make informed decisions with patients. Further information is available at the following link:

https://www.sps.nhs.uk/articles/prescribing-available-medicines-to-treat-adhd/


Written Question
Recycling: Greater London
Thursday 10th October 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the UK Health Security Agency's response to the recent fire at the recycling centre on Weir Road.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

The UK Heath Security Agency (UKHSA) provided expertise in local health protection and environmental hazards to support the response to this incident.

UKHSA engaged with other stakeholders, including the London Fire Brigade and the Environment Agency, as well as the Directors of Public Health for both the London Borough of Wandsworth and the London Borough of Merton. UKHSA assessed the impacts on air quality to inform health advice for residents, and remained involved with the incident until the fire was extinguished.


Written Question
Asthma: Prescriptions
Tuesday 30th July 2024

Asked by: Rosena Allin-Khan (Labour - Tooting)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of adding asthma to the list of long-term medical conditions that are exempt from prescription charges.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

There are no current plans to review the list of medical conditions that entitle someone to apply for a medical exemption certificate. Approximately 89% of prescription items are dispensed free of charge in the community in England, and there are a wide range of exemptions from prescription charges already in place for which those with asthma may be eligible. Eligibility depends on the patient’s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, or whether they are in receipt of certain benefits or a war pension.

People on low incomes can apply for help with their health costs through the NHS Low Income Scheme. Prescription prepayment certificates (PPCs) are also available. PPCs allow people to claim as many prescriptions as they need for a set cost, with three month and 12-month certificates available, and PPCs can be paid for in instalments.